How Has the Primary Cells Market Evolved Historically and What is its Current Size?
The primary cells market has seen considerable growth due to a variety of factors.
• In the last few years, the primary cells market size has seen significant growth. The market will rise from $1.49 billion in 2024 to $1.67 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%.
The increase in the historic period can be linked to the escalating incidence of cancer, boosted investment in regenerative medicine studies, heightened demand for monoclonal antibodies, the benefits of primary human cells compared to cell lines, and a rise in the prevalence of chronic conditions.
What Is The Projected Growth Of The Primary Cells Template Market?
The primary cells market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market size of primary cells is predicted to see a fast expansion. The market is projected to reach $2.46 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.1%.
The growth during this forecast period can be accredited to the rising demand for tailored medicine, expanded emphasis on stem cell research, growing investments, and enhanced adoption of cell-based assays. Key trends of this period comprise the increasing demand for human primary cells, progress in research tools and technologies, and uptake of cell-based therapies.
What Are The Key Drivers Fueling Growth In The Primary Cells Market?
Growth in the primary cells market is predicted to be driven by an increase in government investment for cancer studies. This funding relates to financial aid allocated to an entity, project or person allowing for progress, function, and achievement of set targets. In the case of primary cells, these funds are employed to back research undertakings, gear and infrastructure, the support of employees, educational development, adherence to regulations and the advancement of technology. For exemplification, the American Institute for Cancer Research (AICR), a leading embodiment of American cancer research headquartered in the U.S, called for $49 billion funding in 2023, marking a $4.1 billion rise from 2022's funding of $46.4 billion. This amplifying trend in government monetary support for cancer research is therefore perceived to spur the expansion of the primary cell market.
What Are The Principal Market Segments In The Global Primary Cells Industry?
The primary cells market covered in this report is segmented –
1) By Type: Hematopoietic Cells, Dermatophytes, Gastrointestinal Cells, Hepatocytes, Lung Cells, Renal Cells, Heart Cells, Musculoskeletal Cells, Other Primary Cells
2) By Origin: Human Primary Cells, Animal Primary Cells
3) By End User: Pharmaceuticals, Biotechnology Companies, Contract Research Organizations (CRO), Academic And Research Institutes, Other End Users
Subsegments:
1) By Hematopoietic Cells: Bone Marrow-Derived Cells, Peripheral Blood-Derived Cells
2) By Dermatophytes: Keratinocytes, Fibroblasts
3) By Gastrointestinal Cells: Enterocytes, Goblet Cells, Paneth Cells
4) By Hepatocytes: Liver Parenchymal Cells, Hepatic Stellate Cells
5) By Lung Cells: Alveolar Epithelial Cells, Bronchial Epithelial Cells
6) By Renal Cells: Proximal Tubular Cells, Glomerular Cells
7) By Heart Cells: Cardiomyocytes, Cardiac Fibroblasts
8) By Musculoskeletal Cells: Myoblasts, Chondrocytes
9) By Other Primary Cells: Endothelial Cells, Adipocytes
Pre-Book The Primary Cells Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Primary Cells Market?
In striving to spur scientific research and therapeutic breakthroughs, major businesses in the primary cell market are concentrating on enhancing cell products, such as stem cell and cell culture products. One example of these advancements is a novel serum-free medium; this is a type of culture or growth medium which is necessary for cell or tissue cultivation but lacks serum, specifically fetal bovine serum (FBS) or other animal-derived serums. To illustrate, Bioserve Biotechnologies (India) Private Ltd., a biotech and life sciences solution company based in India, unveiled advanced stem cell products in July 2024. REPROCELL's new offerings are intended to encourage scientific research innovation and drug development, thus supporting progress in regenerative medicine and therapeutic discovery in India.
Who Are the Key Players In The Primary Cells Market?
Major companies operating in the primary cells market are:
• Thermo Fisher Scientific Inc
• Merck KGaA
• BD Biosciences
• Corning Incorporated
• Cytiva
• Lonza Group Ltd
• Charles River Laboratories Inc.
• STEMCELL Technologies Inc
• American Type Culture Collection
• Cell Signaling Technology
• BioIVT
• InvivoGen
• HemaCare Corporation
• Creative Bioarray Inc.
• PromoCell GmbH
• CellGenix
• AllCells LLC
• Axol Bioscience Ltd
• PBS Biotech Inc
• AnaBios Corporation
• ReachBio Research Labs
• PELOBIOTECH GmbH
• Cell Biologics Inc.
• ZenBio Inc.
• StemBioSys Inc
What Are The Regional Insights Into The Primary Cells Market?
North America was the largest region in the primary cells market in 2024. The regions covered in the primary cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
